PH
Pacific Horizon Ventures
Venture CapitalModeratePacific Horizon Ventures is a Seattle-based venture capital firm, with national presence, focused on the life science and healthcare
9
Investments
2
Exits
—
AUM
22.2%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Pacific Horizon Ventures.
Investment Thesis & Strategy
Pacific Horizon Ventures invests in various stages of internet companies, with a focus on life science and healthcare.
Investment Activity
Deals per year over the last 8 years
1
20140
20150
20162
20172
20181
20191
20201
2021Portfolio Companies
Selected investments from their portfolio of 9 companies
V
Vori Health
Healthcare · Series A, 2021
A
Aegle Therapeutics
Biotech · Series A, 2020
L
Locus Biosciences
Biotech · Series A, 2019
V
Vaxcyte
Biotech · Series A, 2018
V
VentureWell
Other · Growth, 2018
T
Triumvira Immunologics
Biotech · Series A, 2017
S
Senti Biosciences
Biotech · Series A, 2017
C
Cellular Dynamics International
Biotech · Growth, 2014
Frequently Asked Questions
Pacific Horizon Ventures focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Madrona Venture Group
Seattle, United States · 359 deals
Vulcan Capital
Seattle, United States · 194 deals
Voyager Capital
Seattle, United States · 152 deals
OVP Venture Partners
Seattle, United States · 115 deals
Washington Research Foundation
Seattle, United States · 54 deals
Second Avenue Partners
Seattle, United States · 43 deals